|
|
Volumn 8, Issue 3, 2004, Pages 303-306
|
|
Aprepitant for chemotherapy-induced nausea and vomiting.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
APREPITANT;
MORPHOLINE DERIVATIVE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
NAUSEA;
NURSING;
ONCOLOGY NURSING;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
VOMITING;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MORPHOLINES;
NAUSEA;
ONCOLOGIC NURSING;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
VOMITING;
MLCS;
MLOWN;
|
|
EID: 3242744579
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/04.cjon.303-306 Document Type: Review |
|
Times cited : (1)
|
|
References (27)
|
